Letter by Calabrò and Gragnano Regarding Article, "Dual Antiplatelet Therapy Continuation Beyond 1 Year After Drug-Eluting Stents: A Meta-Analysis of Randomized Trials"

Circ Cardiovasc Interv. 2017 Aug;10(8):e005636. doi: 10.1161/CIRCINTERVENTIONS.117.005636.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aspirin
  • Drug-Eluting Stents*
  • Percutaneous Coronary Intervention*
  • Platelet Aggregation Inhibitors
  • Randomized Controlled Trials as Topic

Substances

  • Platelet Aggregation Inhibitors
  • Aspirin